Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 33.34% is 18% below its 5-year average of 40.74%, around the middle of its 5-year range (-5.80%–96.22%).
5.03% below its 12-month average of 35.11%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 28.37%.
GROSS MARGIN
33.34%
GROSS MARGIN AVG TTM
35.11%
GROSS MARGIN AVG 3Y
36.13%
GROSS MARGIN AVG 5Y
40.74%
GROSS MARGIN AVG 10Y
63.14%
GROSS MARGIN AVG 15Y
62.70%
GROSS MARGIN AVG 20Y
52.77%
CURRENT VS TTM AVG
-5.03%
CURRENT VS 3Y AVG
-7.73%
CURRENT VS 5Y AVG
-18.17%
CURRENT VS 10Y AVG
-47.20%
CURRENT VS 15Y AVG
-46.83%
CURRENT VS 20Y AVG
-36.83%
SECTOR MEDIAN · HEALTHCARE
42.91%
median of 598 covered companies
CURRENT VS SECTOR MEDIAN
-22.30%
vs the sector median at left
INVO Fertility, Inc.
Market Cap
$1.45M
Gross Margin
33.34%
TTM Avg
35.11%
3Y Avg
36.13%
5Y Avg
40.74%
Market Cap
$1.46M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.40M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.18M
Gross Margin
88.34%
TTM Avg
40.30%
3Y Avg
45.15%
5Y Avg
63.43%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| INVO Fertility, Inc. (IVF) | $1.45M | 33.34% | 35.11% | 36.13% | 40.74% |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.46M | 0.00% | 0.00% | 0.00% | 0.00% |
| PMGC Holdings Inc. (ELAB)vs › | $1.47M | 10.31% | 42.76% | 35.97% | 38.88% |
| Curis, Inc. (CRIS)vs › | $1.47M | 99.28% | 99.31% | 98.49% | 97.34% |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.40M | 0.00% | 0.00% | 0.00% | 0.00% |
| NewcelX Ltd. (NCEL)vs › | $1.39M | 0.00% | 0.00% | 0.00% | 0.00% |
| Genprex, Inc. (GNPX)vs › | $1.31M | 0.00% | 0.00% | 0.00% | 0.00% |
| IM Cannabis Corp. (IMCC)vs › | $1.16M | 13.74% | 16.67% | 17.59% | 25.81% |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.18M | 88.34% | 40.30% | 45.15% | 63.43% |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.10M | 10.32% | 11.11% | 16.34% | 16.34% |
Gross Margin
33.3%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 28.37% |
| 2026-03-31 | 36.12% |
| 2025-12-31 | 33.91% |
| 2025-09-30 | 35.82% |
| 2025-06-30 | 41.32% |
| 2025-03-31 | 36.18% |
| 2024-12-31 | 43.21% |
| 2024-09-30 | 31.03% |
| 2024-06-30 | 53.08% |
| 2024-03-31 | 46.06% |
| 2023-12-31 | 35.82% |
| 2023-09-30 | 40.41% |
| 2023-06-30 | 25.38% |
| 2023-03-31 | 33.62% |
| 2022-12-31 | 71.53% |
| 2022-09-30 | -5.80% |
| 2022-06-30 | 1.79% |
| 2022-03-31 | 60.05% |
| 2021-12-31 | 96.22% |
| 2021-09-30 | 90.67% |
| 2021-06-30 | 93.00% |
| 2021-03-31 | 90.83% |
| 2020-12-31 | 94.81% |
| 2020-09-30 | 91.85% |
| 2020-06-30 | 91.40% |
| 2020-03-31 | 88.40% |
| 2019-12-31 | 91.33% |
| 2019-09-30 | 85.20% |
| 2019-06-30 | 91.61% |
| 2019-03-31 | 94.20% |
| 2018-12-31 | 71.70% |
| 2018-09-30 | 87.71% |
| 2018-06-30 | 84.84% |
| 2018-03-31 | 86.15% |
| 2017-12-31 | 86.37% |
| 2017-09-30 | 81.20% |
| 2017-06-30 | 82.33% |
| 2017-03-31 | 73.50% |
| 2016-12-31 | 67.50% |
| 2016-09-30 | 63.80% |
| 2016-06-30 | 56.26% |
| 2016-03-31 | 82.52% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | -75.57% |
| 2015-06-30 | 108.39% |
| 2015-03-31 | 39.09% |
| 2011-12-31 | 45.43% |
| 2011-09-30 | 74.69% |
| 2011-06-30 | 70.79% |
| 2011-03-31 | 81.17% |
| 2010-12-31 | 72.32% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 67.84% |
| 2010-03-31 | 68.97% |
| 2009-12-31 | -57.30% |
| 2009-09-30 | -29.10% |
| 2009-06-30 | 62.86% |
| 2009-03-31 | 43.86% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
